Statistics

Total Visits

Views
AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER-2 negative recurrent or metastatic BC: PFS analysis54

Select a period of time:

Number of views in the range

Views
AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER-2 negative recurrent or metastatic BC: PFS analysis41

Views

Views
February 20251
March 202515
April 20252
May 20251
June 20253
July 202519
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Brazil11
United States6
Argentina1
Spain1
United Kingdom1
Guyana1
Kenya1
Mexico1
Portugal1
 

Top cities views

Views
Ashburn1
Asunción1
Atlanta1
Betim1
Camaquã1
Campinas1
Council Bluffs1
Franklin1
Georgetown1
Hackney1